The American Cancer Society will launch two national roundtables—one focused on cervical cancer, the other breast cancer—to bring together leading organizations and experts with the goal of improving health equity and access to cancer screening.
FDA has approved Cytalux, a fluorescent imaging agent that binds to cancer cells and allows physicians to identify cancerous lesions during ovarian cancer surgery.
The World Health Organization designated Sylvester Comprehensive Cancer Center, a University of Miami institution, as the first WHO Collaborating Centre for Cervical Cancer Elimination.
Routine screening procedures for breast, colon, and cervical cancers in the first half of 2021 have failed to recover, falling by about a third below historical baselines, even as Americans are resuming normal activities.
